Structure, evolution and expression of the FOXL2 transcription unit by COCQUET, J et al.
Cytogenet Genome Res 101:206–211 (2003)
DOI: 10.1159/000074338
Structure, evolution and expression of the
FOXL2 transcription unit
J. Cocquet,a E. De Baere,b M. Gareil,a M. Pannetier,c X. Xia,d M. Fellous,a and
R.A. Veitiaa
a INSERM E0021 and U361, Reproduction et Physiopathologie Obstétricale, Hôpital Cochin, Paris,
Université Paris VII (France)
b Department of Medical Genetics, Ghent University Hospital, Ghent (Belgium)
c Biologie du Développement et Reproduction, INRA Bât J.Poly, Jouy-en-Josas (France)
d Department of Biology and the Center for Advanced Research in Environmental Genomics, University of Ottawa,
Ottawa, Ontario (Canada)
J.C. is supported by a grant from the French Minister of Education, Research and
Technology (MERT). E.D.B. is supported by the Fund for Scientific Research
(FWO). M.F., M.G. and R.A.V. are funded by the University of Paris VII. X.X. is
funded by the University of Ottawa and Natural Science and Engineering
Research Council of Canada (NSERC).
Received 3 June 2003; manuscript accepted 30 July 2003.
Request reprints from Reiner A. Veitia
INSERM U361, Reproduction et Physiopathologie Obstétricale
Hôpital Cochin, 75014 Paris (France)
telephone: 33 1 43 26 28 26; fax: 33 1 43 26 44 08
e-mail: veitia@cochin.inserm.fr
ABC Fax + 41 61 306 12 34E-mail karger@karger.ch
www.karger.com
© 2003 S. Karger AG, Basel
0301–0171/03/1014–0206$19.50/0
Accessible online at:
www.karger.com/cgr
Abstract. FOXL2 is a putative transcription factor involved
in ovarian development and function. Its mutations in humans
are responsible for the blepharophimosis syndrome, character-
ized by eyelid malformations and premature ovarian failure
(POF). Here we have performed a comparative sequence analy-
sis of FOXL2 sequences of ten vertebrate species. We demon-
strate that the entire open reading frame (ORF) is under purify-
ing selection leading to strong protein conservation. We also
review recent data on FOXL2 transcript and protein expres-
sion. FOXL2 has been shown 1) to be the earliest known sex
dimorphic marker of ovarian determination/differentiation in
vertebrates, 2) to have, at least in mammals, an ovarian expres-
sion persisting until adulthood. The conservation of its se-
quence and pattern of expression suggests that FOXL2 might
be a key factor in the early development of the vertebrate
female gonad and involved later in adult ovarian function.
Finally, we provide arguments for the existence of an alterna-
tive transcript in rodents, that may arise from a differential
polyadenylation. Although it has only been demonstrated in
rodents, its presence/absence in other species deserves further
investigation.
Copyright © 2003 S. Karger AG, Basel
FOXL2 is a putative winged helix/forkhead transcription
factor gene (MIM 605597) involved in ovarian development
and function. Its dominant mutations have recently been
shown to be responsible for the blepharophimosis syndrome (or
BPES for Blepharophimosis Ptosis Epicanthus inversus Syn-
drome, MIM 110100) a rare genetic disease characterized by
eyelid malformations associated with premature ovarian fail-
ure (POF) (BPES type I) or occurring isolated (BPES type II)
(Zlotogora et al., 1983; Crisponi et al., 2001; De Baere et al.,
2001). Until now, no clear-cut pathogenic mutations have been
found in patients affected with isolated POF (De Baere et al.,
2002; Harris et al., 2002).
As a member of the large family of winged helix/forkhead
transcription factors, FOXL2 contains a characteristic 110-
amino acid DNA-binding domain, the forkhead. Many fork-
head proteins are known to be involved in different develop-
mental and metabolic processes (Kaufmann and Knöchel,
1996; Carlsson and Mahlapuu, 2002) and mutations in some of
them are responsible for genetic developmental diseases (Carls-
son and Mahlapuu, 2002). FOXL2 also contains a polyalanine
tract (polyAla), whose role (if any) has not been identified yet.
Expansions from 14 to 24 alanine residues in this region repre-
sent 30% of all FOXL2 mutations detected in the ORF and
lead mainly to BPES type II (De Baere et al., 2003). 
The nucleotide and amino acid sequences of FOXL2 in four
vertebrates, ranging from fish to man, have previously been
compared and shown to be highly conserved (Cocquet et al.,
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Table 1. Estimated ratio of synonymous (dS) and non-synonymous (dN) substitution rates obtained using the CODEML
program in the PAML package (lower matrix, Yang, 2002). t: Genetic distances based on dS and dN (upper matrix). Pairwise
comparisons result in very low dN/dS ratios confirming FOXL2 protein is under a strong purifying selection throughout evolu-
tion
dN/dS, t Human Goat Cow Pig Rabbit Mouse Rat Pufferfish Zebrafish Tetraodon 
Human  0.4811 2.1789 0.0271 0.3775 0.3826 0.2809 17.9228 39.0000 32.1378 
Goat 0.0039  0.0812 2.9036 0.3764 0.4427 2.8280 39.0000 39.0000 39.0000 
Cow 0.0010 0.0168  3.0764 0.3681 0.5533 2.9948 39.0000 39.0000 39.0000 
Pig 0.0306 0.0010 0.0010  0.4167 0.3388 0.3026 26.0215 39.0000 39.0000 
Rabbit 0.0053 0.0040 0.0045 0.0068  0.2130 0.5005 22.1978 39.0000 32.8754 
Mouse 0.0051 0.0029 0.0024 0.0086 0.0081  0.4178 39.0000 39.0000 39.0000 
Rat 0.0028 0.0010 0.0010 0.0055 0.0064 0.0077  24.9313 39.0000 39.0000 
Pufferfish 0.0026 0.0012 0.0012 0.0019 0.0019 0.0012 0.0020  33.1133 0.2717 
Zebrafish 0.0022 0.0021 0.0023 0.0023 0.0021 0.0022 0.0023 0.0011  30.2038 
Tetraodon 0.0014 0.0011 0.0012 0.0012 0.0012 0.0012 0.0012 0.0034 0.0011  
2002). Here, we have performed a broader comparative analy-
sis including seven mammalian and three non-mammalian ver-
tebrate species. We confirm and extend our findings showing
the conservation of the FOXL2 open reading frame (ORF) and
protein sequences, especially at the level of the forkhead
domain and the C-terminal region, while the homopolymeric
runs of amino acids, such as the polyalanine tract, are less con-
served. 
The expression of FOXL2 has already been studied exten-
sively by us and others, in mammals (Crisponi et al., 2001; Coc-
quet et al., 2002) as well as in non-mammalian vertebrate spe-
cies (Loffler et al., 2003). Here, we review recent data on
FOXL2 mRNA and protein pattern of expression and also pro-
vide novel data on protein expression in the human developing
eyelid and peri-ocular muscles. 
In addition, we provide evidence for the existence of a sec-
ond alternative transcript in rodents, which is likely to result
from a differential polyadenylation. Our results strongly sug-
gest that this second transcript contains the entire Foxl2 ORF.
FOXL2 protein sequence is highly conserved
In a previous study, we have demonstrated that the FOXL2
protein is highly conserved in four species (human, goat, mouse
and pufferfish) and is under a purifying selection (Cocquet et
al., 2002). We aimed to extend our study by performing an
analysis in other mammalian and non-mammalian sequences.
FOXL2 sequences for Homo sapiens (human), Capra hircus
(goat), Mus musculus (mouse), Rattus norvegicus (rat) and Fugu
rubripes (pufferfish) were collected or assembled from Gen-
Bank (AI: AF301906, AY112725, AF522275, AC105826 and
Scaffold–8165/ProtJGI–24134, respectively). The Danio rerio
(zebrafish) and Tetraodon nigroviridis (tetraodon) sequences
were obtained from public genome resources by interrogating
them with the pufferfish Foxl2 sequence. Sus scrofa (pig), Oryc-
tolagus cuniculus (rabbit), Bos taurus (cow) and Macropus euge-
nii (tammar wallaby) sequences were directly obtained by PCR
on genomic DNA using the primers described previously
(pBAD-FOXL2F and pBAD-FOXL2R; Cocquet et al., 2002)
and the primer FOXL2-R420: 5) CTC GAA CAT GTC PyTC
GCA GGC CGG GTC 3) (AI: AY340971 for S. scrofa, AY
340972 for O. cuniculus, AY340970 for B. taurus and AY
340969 for M. eugenii). 
We have previously used Li’s method to compare the
FOXL2 coding sequence among different species (Li, 1993;
Cocquet et al., 2002). However, a statistically more justifiable
method to calculate the rate of synonymous substitutions (dS)
(i.e. when a change in the nucleotide sequence does not lead to a
change in the corresponding amino acid) and non-synonymous
(dN) substitutions between a pair of homologous sequences
is the maximum likelihood method implemented in the
CODEML program of the PAML package (Yang and Bielaws-
ki, 2000; Yang, 2002; Xia 2001). We used therefore this meth-
od to compare FOXL2 nucleotide and protein sequences in all
the above mentioned species. The ratio dN/dS is a good indica-
tor of the selective pressure at the protein level: dN/dS = 1
implies no selection; dN/dS ! 1, a purifying selection; and
dN/dS 1 1, a positive selection (Yang and Bielawski, 2000).
Pairwise comparisons resulted in low dN/dS ratios confirm-
ing that FOXL2 is under a strong purifying selection through-
out evolution (Table 1). We also calculated the genetic dis-
tances based on dN and dS results (t, Table 1). Interestingly, the
multiple alignment of the protein sequences shows that homo-
polymeric runs of amino acids are not conserved among spe-
cies, in contrast with the high conservation of the rest of the
protein (Fig. 1). Indeed, in the seven eutherian mammals stud-
ied, the length of the polyalanine region is strictly conserved
(i.e. 14 residues) whereas in the three fish species this domain is
absent. This suggests that the polyAla tract length in mammals
is under strong constraints limiting its maximum length to 14
residues. This view is supported by the deleterious effect of its
expansion in the blepharophimosis syndrome (30% of reported
mutations, De Baere et al., 2003). The aforementioned con-
straints are probably structural rather than functional, as sever-
al studies have shown that alanine runs present in mammalian
genes are absent or shortened in non-mammalian homologues
(Nakachi et al., 1997; Cocquet et al., 2003). However, the
polyAla tract might tune transcription factor activity (Nakachi
et al., 1997; Cocquet et al., 2003) with 14 Ala residues being the
optimum length for FOXL2 function in mammals. This would
explain why the polyAla tract, when present, is always (as far as
observed) composed of 14 residues. Interestingly, an isolated
POF case carrying a FOXL2 allele with a shorter polyAla
208 Cytogenet Genome Res 101:206–211 (2003)
Fig. 1. Multiple alignment of FoxL2 protein
of ten species. M: Mus musculus, mouse (Gen-
Bank AI: AF522275); R: Rattus norvegicus, rat
(AI: AC105826 ); B: Bos taurus, cow (AI:
AY340970); C: Capra hircus, goat (AI:
AY112725); S: Sus scrofa, pig (AI: AY340971); H:
Homo sapiens, human (AI: AF301906); O: Oryc-
tolagus cuniculus, rabbit (AI: AY340972); F: Fugu
rubripes, pufferfish (AI: Scaffold_8165/Prot
JGI_24134); T: Tetraodon nigroviridis, tetraodon;
D: Danio rerio, zebrafish and of FoxL2 partial
protein of the Macropus eugenii (Ma), tammar
wallaby (AI: AY340969). The regions of the
FOXL2 primers used for PCR amplification are
represented in italics. The forkhead domain and
the polyalanine region are indicated in bold.
Asterisks indicate fully conserved sites. Notice
that many of the changes are highly conservative.
           10        20        30       40        50       60        70        80 
   ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|---
M  MMASYPEPEDTAGTLLAPESGRAVKEAEASPP-SPGKGGG----------TTPEKPDPAQKPPYSYVALIAMAIRESAEKRLT
R  MMASYPEPEDTAGTLLSPESGRAVKEAEASPP-SPGKGGG----------TAPEKPDPAQKPPYSYVALIAMAIRESAEKRLT
B  MMASYPEPENASGALLAPETGRAAKEPEAPPPPSPGKGGGGGTG------TAPEKPDPAQKPPYSYVALIAMAIRESAEKRLT
C  MMASYPEPEDASGALLAPETGRAAKEPEAPAPPSPGKGGGGGAG------AAPEKPDPAQKPPYSYVALIAMAIRESAEKRLT
S  MMASYPEPEDAAGALLAPETGRTAKEPEAPPPLSPGKGGGGGAS------TAPEKPDPAQKPPYSYVALIAMAIRESAEKRLT
H  MMASYPEPEDAAGALLAPETGRTVKEPEGPPP-SPGKGGGGGGG------TAPEKPDPAQKPPYSYVALIAMAIRESAEKRLT
O  MMASYPEPEEAAGALLAPESGRAAKEPEAPPP-SPGKGGGGGGGGGS----AAEKPDPAQKPPYSYVALIAMAIRESAEKRLT
F  MMATYQNPEDDAMALMVHDTNTTKEKERPKEEPVQDK--------------VEEKPDPSQKPPYSYVALIAMAIRESSEKRLT
T  MMATYQNPEDDAMALMIHDTNTTKEKERPKEEPVQDK--------------VEEKPDPSQKPPYSYVALIAMAIRESSEKRLT
D  MMATYPGHEDNGMILMDT-TSSSAEKDRTKDEAPPEK--------------GPDKSDPTQKPPYSYVALIAMAIRESSEKRLT
Ma MMASYPEPEDDAGALLAPEPATGRPGKDSEPRGPRDCKEELSPEKSGGGGGVAEKPDPSQKPPYSYVALIAMAIRESAEKRLT
   ***…*………*……………*………………………………………………………………………………………………………*…**…******************…*****
         90       100       110       120      130       140       150      160 
    -|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|-- 
M   LSGIYQYIIAKFPFYEKNKKGWQNSIRHNLSLNECFIKVPREGGGERKGNYWTLDPACEDMFEKGNYRRRRRMKRPFRP 
R   LSGIYQYIIAKFPFYEKNKKGWQNSIRHNLSLNECFIKVPREGGGERKGNYWTLDPACEDMFEKGNYRRRRRMKRPFRP 
B   LSGIYQYIIAKFPFYEKNKKGWQNSIRHNLSLNECFIKVPREGGGERKGNYWTLDPACEDMFEKGNYRRRRRMKRPFRP 
C   LSGIYQYIIAKFPFYEKNKKGWQNSIRHNLSLNECFIKVPREGGGERKGNYWTLDPACEDMFEKGNYRRRRRMKRPFRP 
S   LSGIYQYIIAKFPFYEKNKKGWQNSIRHNLSLNECFIKVPREGGGERKGNYWTLDPACEDMFEKGNYRRRRRMKRPFRP 
H   LSGIYQYIIAKFPFYEKNKKGWQNSIRHNLSLNECFIKVPREGGGERKGNYWTLDPACEDMFEKGNYRRRRRMKRPFRP 
O   LSGIYQYIIAKFPFYEKNKKGWQNSIRHNLSLNECFIKVPREGGGERKGNYWTLDPACEDMFEKGNYRRRRRMKRPFRP 
F   LSGIYQYIISKFPFYEKNKKGWQNSIRHNLSLNECFIKVPREGGGERKGNYWTLDPACEDMFEKGNYRRRRRMKRPFRP 
T   LSGIYQYIISKFPFYEKNKKGWQNSIRHNLSLNECFIKVPREGGGERKGNYWTLDPACEDMFEKGNYRRRRRMKRPFRP 
D   LSGIYQYIISKFPFYEKNKKGWQNSIRHNLSLNECFIKVPREGGGERKGNYWTLDPACEDMFEKGNYRRRRRMKRPFRP 
Ma  LSGIYQYIIGKFPFYEKNKKGWQNSIRHNLSLNECFIKVPREGGGERKGNYWTLDPACEDMFE  
…………*********…********************************************************************* 
 
          170       180      190       200      210       220       230       240 
    --|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|- 
M   PPAHFQPGKGLFGSGGAAGGCGVPGAGADGYGYLAPPKYLQSGFLNNSWPLPQPPSPMPYASCQMAAAAAAAAAAAAAA 
R   PPAHFQPGKGLFGSGGGAGGCGVPGAGADGYGYLAPPKYLQSGFLNNSWPLPQPPSPMPYASCQMAAAAAAAAAAAAAA 
B   PPAHFQPGKGLFGAGGAAGGCGVAGAGADGYGYLAPPKYLQSGFLNNSWPLPQPPSPMPYASCQMAAAAAAAAAAAAAA 
C   PPAHFQPGKGLFGAGGAAGGCGVAGAGADGYGYLAPPKYLQSGFLNNSWPLPQPPSPMPYASCQMAAAAAAAAAAAAAA 
S   PPAHFQPGKGLFGAGGAAGGCGVAGAGADGYGYLAPPKYLQSGFLNNSWPLPQPPSPMPYASCQMAAAAAAAAAAAAAA 
H   PPAHFQPGKGLFGAGGAAGGCGVAGAGADGYGYLAPPKYLQSGFLNNSWPLPQPPSPMPYASCQMAAAAAAAAAAAAAA 
O   PPAHFQPGKGLFGAAGAAGGCGVAGAGADGYGYLAPPKYLQSGFLNNSWPLPQPPSPMPYASCQMAAAAAAAAAAAAAA 
F   PPTHFQPGKSLFG--------------GDGYGYLSPPKYLQSSFMNNSWSLGQPPAPMSYTSCQMASGNVSPVN----- 
T   PPTHFQPGKSLFG--------------GDGYGYLSPPKYLQSSFMNNSWSLGQPPPPMSYTSCQMASGNVSPVN----- 
D   PPTHFQPGKSLFG--------------GEGYGYLSPPKYLQSGFINNSWS----PAPMSYTSCQVSSGSVSPVN----- 
    **…**********…………………………………………*****…******* *…****……………*…**…*.***……………………………………… 
 
           250       260      270       280      290       300      310       320 
    ---|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| 
M   GPGSPGAAAVVKGLAGPAASYGPYSRVQSMALPPGVVNSYNGLGGPPAAPPPPPPPP---HPHPHPHAHHLHAAAAPPP 
R   GPGSPGAAAVVKGLAGPAASYGPYSRVQSMALPPGVVNSYNGLGGPPAAPPPPPPR----HPHPHPHAHRLHAAAAPPP 
B   GPGSPGAAAVVKGLAGPAASYGPYSRVQSMALPPGVVNSYNGLGGPPAAPPPPP------HPHSHPHAHHLHAAAAPPP 
C   GPGSPGAAAVVKGLAGPAASYGPYSRVQSMALPPGVVNSYNGLGGPPAAPPPPP------HPHSHPHAHHLHAAAAPPP 
S   GPGSPGAAAVVKGLAGPAASYGPYSRVQSMALPPGVVNSYNGLGGPPAAPPPPP------HPHSHPHAHHLHAAAAPPP 
H   GPGSPGAAAVVKGLAGPAASYGPYTRVQSMALPPGVVNSYNGLGGPPAAPPPPP------HPHPHPHAHHLHAAAAPPP 
O   GPGSPGAAAVVKGLAGPAASYGPYSRVQSMALPPGVVNSYNGLGGPPAAPPPPPPPPPPPHPHPHPHAHHLHAAAAPPP 
F   ----------VKGLSAP-TSYNPYSRVQSMALPS-MVNSYNGMS-------------------HHHHPAHPH-------
T   ----------VKGLSAP-TSYNPYSRVQSMALPS-MVNSYNGMS-------------------HHHHPAHPH-------
D   ----------MKGLSAP-SSYNPYSRVQSIGLPS-MVNSYNGIS-------------------HHHHHHHTHPHALP--
………………………………………***……*……**…**…****……**………******…………………………………………………………*…*… ……*
 
            330      340       350       360      370       380      390   
    ----|----|----|----|----|----|----|----|----|----|----|----|----|----|  
M………APPHHGAAAPPPGQLSPASPATAAPPAPAPTSAPGLQFACARQP-ELAMMHCSYWDHDSKTGALHSRLDL  
R   APPHHGAAAPPPGQLSPASPATAAPPAPAPTSAPGLQFACARQP-ELAMMHCSYWDHDSKTGALHSRLDL  
B   APPHHGAAAPPPGQLSPASPATAAPPAPAPTNAPGLQFACARQP-ELAMMHCSYWDHDSKTGALHSRLDL  
C   APPHHGAAAPPPGQLSPASPATAAPPAPAPTNAPGLQFACARQP-ELAMMHCSYWDHDSKTGALHSRLDL  
S   APPHHGAAAPPPGQLSPASPATAAPPAPAPTNAPGLQFACARQP-ELAMMHCSYWDHDSKTGALHSRLDL  
H   APPHHGAAAPPPGQLSPASPATAAPPAPAPTSAPGLQFACARQP-ELAMMHCSYWDHDSKTGALHSRLDL  
O   APPHHGAAAPPPGQLSPASPATAAPPAPAPTSAPGLQFACARQP-ELAMMHCSYWDHDSKTGALHSRLDL  
F   -------------HAQQLSPATAAPPPVSSSNGAGLQFACSRQPAELSMMHCSYWEHETKHSALHTRIDI  
T   -------------HAQQLSPATAAPPPVSSSNGAGLQFACSRQPSEFSMMHCSYWEHETKHSPYHTRIDI  
D   -------------HAQQLSPATAAAPPVTTGNGTGLQFACSRQPAELSMMHCSYWDHESKHSALHARIDI  
…………………………………………………………******…*……………………******…***…*……*******…*……*…………*…*…*… 
stretch has been reported (Harris et al., 2002) but further stud-
ies are required to establish a formal link between polyAla con-
traction and isolated POF. Other amino acid repeats in FOXL2
(such as proline [Pro], glycine [Gly]) have unequal lengths in
mammals and are absent in fishes. In a recent genomic study,
we have shown that human proteins containing polyAla tracts
have a tendency to carry runs of other amino acids, encoded, as
alanine, by GC-rich codons (i.e. Gly, Pro and histidine [His]).
Besides, the Ala, Gly, Pro and His contents of these proteins are
correlated with the GC contents of the third codon base, sug-
gesting that their amino acid composition reflects the con-
straints operating on the genomic compartments in which their
ORFs lie (i.e. isochores) (Cocquet et al., 2003). Compositional
constraints acting on the FOXL2 ORF may be different
between mammals and fishes and could explain the differences
of amino acid runs that we have observed.
Our analysis also reveals that the N-terminal region of
FOXL2 (the first 45 amino acids) is less conserved than the
C-terminal region, when excluding low complexity repeats (i.e.
homopolymeric runs). Note that, in the latter region, most of
amino acid changes are highly conservative. Thus, the N-termi-
nal region might be responsible for functional differences
among species or has a less important role (if any) in FOXL2
function. On the contrary, the well-conserved C-terminal re-
gion might contain yet unidentified functional domain(s).
We focused then on the forkhead domain, including the
sequences of the horse (Equus caballus), obtained by PCR as
previously described, the chicken (Gallus gallus) and the turtle
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(Trachemys scripta) (respective AI: AY155534 and
AY155535). We found that the amino acid sequence is identi-
cal among eutherian mammals and that only a few minor
changes, at three sites, exist when we extend the comparison to
other vertebrates (alignment available from authors upon re-
quest). These changes concern amino acids that are not charged
and thus do not disturb the global isoelectric point of the fork-
head domain, estimated to be 10.87 in all the studied species.
This highly basic isoelectric point has to be correlated with the
DNA-binding activity of this domain.
The sequence and properties of FOXL2 forkhead domain
are highly conserved, which is a general characteristic of fork-
head transcription factors (Carlsson and Mahlapuu, 2002). 
FOXL2 pattern of expression
The pattern of expression of FOXL2 has already been stud-
ied at both the mRNA and protein levels in different species
and has provided interesting insights. In human, mouse and
goat FOXL2 has only been detected in developing eyelids and
in fetal and adult ovaries while it has not been detected in testis
at any stage. Its protein localization has been shown to be
nuclear, which is in line with its putative function as a tran-
scription factor (Crisponi et al., 2001; Cocquet et al., 2002). 
Here, we provide data on FOXL2 protein expression in
human developing eyelids: as shown in Fig. 2, it is located in a
wide region of the primordial mesenchyma of the developing
eyelids. Magnetic resonance imaging (MRI) performed on the
orbit of BPES patients has revealed the absence or hypotrophy
of the eyelid superior levator muscle (Dollfus et al., 2003). The
authors have suggested that FOXL2 may be involved in the
development of this muscle. However, the much wider expres-
sion domain of the protein (in the bulging and surrounding pri-
mordial mesenchyma, Fig. 2) also suggests a role in the devel-
opment of other peri-ocular muscles, which is supported by
their same mesodermal origin and the relatively frequent obser-
vation of strabismus in BPES patients (Oley and Baraitser,
1988; Barishak et al., 1992).
FOXL2 ovarian expression in mammals begins early in
development, before the onset of folliculogenesis, and persists
until adulthood. It is restricted to the somatic compartment:
the follicular (granulosa) cells display a strong protein expres-
sion, the stromal cells a more diffuse one, whereas in the
oocytes no signal has been observed (Cocquet et al., 2002; Pan-
netier et al., 2003). The staining of the mouse stromal cells is
almost undetectable, in line with the RNA in situ hybridization
results of Crisponi et al. (2001). In a recent study, Foxl2 mRNA
has been observed in both granulosa cells and some oocytes of
fetal and adult mouse ovaries (Loffler et al., 2003). Low levels
of FOXL2 transcript have been detected in goat and mouse tes-
tis, at fetal and adult stages, but no protein could be found in
any of those tissues (Pailhoux et al., 2001; Cocquet et al., 2002;
Pannetier et al., 2003). Thus, either the levels of transcript are
too weak to be significant, or its expression undergoes a post-
transcriptional or translational regulation. One of these hypoth-
eses may also explain the presence of Foxl2 transcript in some
mouse oocytes where the protein remains undetectable. 
Fig. 2. Immunohistochemistry performed with anti-C-terminal FOXL2
antibody on human developing eyelid section (7th week, Carnegie stage 19)
as previously described (Cocquet et al., 2002). FOXL2 is expressed in the
bulging and surrounding primordial mesenchyma suggesting a role in the
development of extra-ocular muscles consistent with the BPES phenotype
(Oley and Baraitser, 1988).
surrounding primordial 
mesenchyma
lens
cornea
retina
primordial mesenchyma
of the bulging eyelids
Interestingly, mouse Foxl2 transcript (previously named P-
Frk for Pituitary forkhead factor) is also expressed in the pitu-
itary Rathke’s pouch (Treier et al., 1998) and has thus been
suggested to be involved in pituitary organogenesis. Recently,
protein expression has been shown to be consistent with these
results (Buffy Ellsworth, personal communication).
Many forkhead proteins are responsible for differentiation
processes during development and are later recycled to control
metabolism in the adult (Carlsson and Mahlapuu, 2002). The
ovarian somatic expression of FOXL2 in mammals beginning
at an early stage of development and persisting in adult life sug-
gests a similar dual role: at first, in the ovarian somatic cell
determination/differentiation and later, in maintenance of the
adult ovarian function.
In non-mammalian vertebrates, Foxl2 mRNA has also been
shown to be expressed at an early stage in the developing female
gonad and to have a sex-dimorphic expression. In the chicken,
it is expressed in the two ZW (female) gonads at early stages of
development (at least from day 5 to 8) whereas no expression
was found in male gonads at the same stages. In the turtle, a
species undergoing temperature-dependent sex determination,
Foxl2 is expressed in the developing gonads at a higher level at
female than male promoting temperatures (Loffler et al., 2003).
The conservation of FOXL2 sequence and pattern of ex-
pression throughout evolution leads to the conclusion that it is,
by now, the earliest known sex-dimorphic marker of ovarian
determination/differentiation in vertebrates and might be a key
gene in early development and maintenance of the vertebrate
female gonad. 
Rodents possess alternative Foxl2 transcripts
The previous discussion demonstrates a strong conservation
of FOXL2 sequence and pattern of expression among different
species. Nevertheless, when exploring the GenBank expressed
sequence tag (EST) division, we found a potentially interesting
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Fig. 3. RT-PCR analysis of mouse Foxl2 at different developmental
stages (12, 15.5 days post coitum and 5, 15, 40 days post partum) and in the
mouse granulosa cell line AT29C. cDNAs are normalized with respect to ß
actin (as in Pannetier et al., 2003). (A) Upper panel: RT-PCR that amplifies
370 bp of Foxl2 ORF using primers pBAD-FOXL2F, described above, and
FOXL2-B, described by Crisponi et al. (2001). Lower panel: amplification
with primers specific of the Foxl2 second transcript (amplicon length: 415
bp). (M) and (F) stand for male and female, respectively. (RT+): adult ovary
cDNA. (RT–): adult ovary mRNA, no reverse transcriptase (negative con-
trol). Granulosa: mouse granulosa cell line AT29C with (RT+) or without
(RT–) reverse transcriptase. (B) RT-PCR with primers that amplify from the
beginning of the Foxl2 ORF to the end of the second transcript (pBAD-
FOXL2F and mFoxl2polyAde-R, described above; amplicon length: 2.7 kb).
(RT+): adult ovary cDNA. (RT–): adult ovary mRNA, no reverse transcrip-
tase (negative control).
Foxl2 second 
transcript
Foxl2 ORF RT-
M FF FF FM MMM
12 dpc 15.5 dpc 5 dpp 15 dpp 40 dpp
RT+
adult 
ovaries granulosa
++ - -
RT-
difference between rodents and other species: at least in mouse
and rat there may be two alternative Foxl2 transcripts. Several
ESTs, carrying a standard polyadenylation signal (AAUAAA),
were found to end as expected from the comparison with the
human sequence (for the mouse BG071987, AU046041,
AU045768, AU045128, BB334136, for the rat AA850108).
However we also detected other ESTs that run beyond this
point in both rodents. In mouse ESTs BB556269, AW558663,
BG076281, BB441670 are representative of this “longer” tran-
script, carrying a putative polyadenylation signal (AATA-
TAAA) while for the rat ESTs, BU758851 and AI556368 would
carry another non-canonic AAGAAT signal. These potential
polyadenylation sites are located about 430 bp downstream of
the known one. The perfect alignment of these ESTs with the
genomic sequences suggests that these alternative transcripts
would result from a differential polyadenylation. 
To explore this observation experimentally, we performed
RT-PCR experiments using primers specific for this putative
alternative transcript: mFoxl2polyAde-F (5) GAACTAGAG-
CACTTTTGTTGT 3)) located 59 bp upstream of the first
polyadenylation signal and mFoxl2polyAde-R (5) CACCTAG-
TACAATTATGTAAGAG 3)) located 350 bp downstream.
These experiments were conducted on cDNA from mouse
gonads at different developmental stages (normalized with
respect to ß actin, as in Pannetier et al., 2003, in this issue) and
on a mouse granulosa cell line (AT29C-U493, described by
Dutertre et al., 2001). The Foxl2 second transcript was detected
in female gonads, from 15.5 days post coitum (dpc) with an
increasing level and persisting at adulthood. In male gonads,
very faint levels were observed (Fig. 3A). The results obtained
for the Foxl2 ORF amplification were very similar, with the
exception that it could be faintly detected in female gonads at
12 dpc (Fig. 3A, in line with the results obtained by Pannetier et
al., 2003). This correlation between the profiles of the ORF and
the second transcript suggests that the latter encompasses the
Foxl2 ORF. This is further suggested by the existence of an
amplicon running from the beginning of the Foxl2 ORF to the
end of the second transcript, obtained with adult mouse ovary
cDNA (Fig. 3B). This implies that the Foxl2 ORF amplifica-
tions represent, in fact, both transcripts (Fig. 3A).
The experiments described previously have shown the pres-
ence of Foxl2 transcript and protein in the follicular cells (i.e.
granulosa) of adult mouse ovaries. Interestingly, by RT-PCR
we have not detected the second transcript in the mouse granu-
losa cell line AT29C, while the first one was detected (Fig. 3A).
Either this may be a specificity of this cell line or may be due to
the fact that the second transcript is not expressed in the granu-
losa but in another ovarian compartment. Further studies are
required to evaluate the potential existence of other alternative
transcripts. For instance, rat EST AW920539 would represent
an even shorter transcript, if artifactual RT-priming is ruled
out (since there is a polyadenylate stretch immediately down-
stream of the AAUAAA site). Indeed this polyadenylation site
(F770 bp downstream of the stop codon) is the optimum rec-
ognized by the Genscan program in human, rat and mouse.
ESTs BG088806 and BF544943, among others, seem to start
downstream of the Foxl2 stop codon (more details in a manu-
script in preparation). It would be interesting to assess whether
the existence of alternative transcripts has a functional signifi-
cance or not.
Besides, although a similar region exists in human, there is
no EST-based evidence of the existence of a longer human
transcript. This is consistent with Northern blot experiments
on human ovary RNA where only one FOXL2 transcript has
been detected (Crisponi et al., 2001). However, the presence/
absence of an alternative transcript in human and other species
deserves more in-depth studies. This might be relevant to
understanding FOXL2 function. Further studies in animal
models, such as a conditional knock-out mouse model for
Foxl2 might allow us to shed light on potential species-specific
differences, and also on the implication of FOXL2 in early
ovarian development and later during adult female life.
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